releases Archive - Page 2 of 11 - biolight

Condensed Business Update And Voluntary Financial Information as of March 31, 2024

Results of meeting held on May 9, 2024

Sale of all of BioLight’s shares (Exit) in Belkin Vision (portfolio company) as part of a merger transaction of Belkin with Alcon

AEYE Health gains additional FDA clearance – autonomous AI for portable diabetic retinopathy screening

Final results in a clinical trial in India for DiagnosTear product

Results of meeting held on April 8, 2024

Engagement in a research collaboration and option agreement for the grant of an exclusive license to a global pharmaceutical company for a drug based on OphRXtechnology (subsidiary company)

DiagnosTear Ltd. (Subsidiary) – Receipt of grant from the Israeli Innovation Authority

Belkin Vision product received FDA

FDA registration for Peripherex’ Product

* The use of the information and data on the site are at the sole responsibility of the user. There may be cases in which the information appearing on the Site will contain errors and/or disruptions and/or errors and/or inaccuracies and/or omissions. In any case of discrepancy between the data as they appear on the site and the reported data to the Tel Aviv Tock Exchange, the reported data will be determined in accordance with the provisions of the law. The data of the financial statements, immediate reports and main events are taken from the Tel Aviv Stock exchange reporting website (MAGNA).